Bausch Health Companies Inc. (BHC) Profit Margins
Over the twelve months to 2026-06-30, Bausch Health Companies Inc. (BHC) had gross margin 71.8%, operating margin 8.1%, net margin -10.1%, free cash flow margin 13.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BHCBausch Health Companies Inc.Follow BHC — free
—
Price chart with a free account
- Market cap
- 2.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 66.5% | 71.8% | 74.0% | 68.0% | 73.5% | 75.8% | 73.4% | 71.3% | — | — | — | 71.6% | 70.9% | 70.8% | 71.1% | 70.7% | 71.8% | |
| Operating margin | -9.3% | 12.4% | 2.3% | -7.1% | 24.4% | 14.6% | -5.9% | 1.2% | -28.4% | -2.4% | 8.4% | 5.3% | 5.6% | 11.0% | 16.1% | 17.7% | 8.1% | |
| Net margin | 31.0% | 6.6% | -3.3% | -15.0% | 10.7% | -2.8% | -24.9% | 27.6% | -49.5% | -20.8% | -7.0% | -11.2% | -2.8% | -6.8% | -0.5% | 1.5% | -10.1% | |
| FCF margin | 20.9% | 24.0% | 15.8% | 16.1% | 24.6% | 19.4% | 19.1% | 24.3% | 16.0% | 14.3% | 10.1% | 13.7% | -11.6% | 9.3% | 13.1% | 9.8% | 13.2% |
USD billions · SEC XBRL
Bausch Health Companies Inc. — questions
- What is Bausch Health Companies Inc.'s gross margin?
- 71.8% over the twelve months to 2026-06-30.
- What is Bausch Health Companies Inc.'s operating margin?
- 8.1% over the twelve months to 2026-06-30.
- What is Bausch Health Companies Inc.'s net profit margin?
- -10.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Bausch Health Companies Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.